logo-large
  • Browse Categories

Publications by authors named "I-Chung Tang"

Claim this Profile
D
Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors.
Ming-Cheng Chang, Chun-Tang Chen, Ping-Fang Chiang, I-Chung Tang, Cheng-Liang Peng

Int J Mol Sci· July 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Therapeutic Potential of Lu-PSMA-617 in a Mouse Model of Prostate Cancer Bone Metastases.
Cheng-Liang Peng, Chun-Tang Chen, I-Chung Tang

Int J Mol Sci· June 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of Re-188-MN-16ET-lipiodol and transcatheter arterial chemoembolization in the treatment of hepatoma: an animal study.
Wan-Yu Lin, Tsai-Yueh Luo, Shih-Chung Tsai, Chia-Hung Kao, I-Chung Tang

Nucl Med Biol· April 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the potential of (188)Re-ECD/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment.
Tsai-Yueh Luo, Ying-Hsia Shih, Chiung-Yu Chen, I-Chung Tang, Yu-Long Wu

Cancer Biother Radiopharm· October 2009


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: